Research Leading to Ozempic Honored by 2024 Lasker Awards
WEB3 days ago · This year’s Lasker-DeBakey Clinical Medical Research Award went to three scientists for their work on GLP-1, the hormone that led to drugs like Wegovy (the same compound is the basis for Ozempic ...
GLP-1-based therapy for obesity - Lasker Foundation
WEBThe 2024 Lasker~DeBakey Clinical Medical Research Award honors three scientists for their discovery and development of GLP-1-based drugs that have revolutionized the treatment of obesity.Joel Habener (Massachusetts General Hospital) and Svetlana Mojsov (The Rockefeller University) discerned the physiologically active form of the hormone, and Lotte Bjerre Knudsen (Novo Nordisk) turned it into ...
Long-overlooked scientist shares Lasker Award with other GLP-1 …
WEB2 days ago · Announced on Thursday in New York, the Lasker-DeBakey Clinical Medical Research Award will be shared by Svetlana Mojsov and Joel Habener, who identified and characterized the GLP-1 hormone in the ...
Harvard Medical School Researcher Wins 2024 Lasker Award for …
WEB2 days ago · Harvard Medical School researcher Joel Habener has won the 2024 Lasker~DeBakey Clinical Medical Research Award for his discovery of glucagon-like peptide-1 (GLP-1), a molecule that has become the basis for therapies which have transformed the treatment of obesity.Lasker awards, sometimes called “America’s Nobels,” are among the world’s most prestigious biomedical and clinical research ...
Chemistry Matters—From a Putative Peptide to Effective …
WEB3 days ago · In this Viewpoint, 2024 Lasker-DeBakey Clinical Medical Research Award winner Svetlana Mojsov describes her discovery of GLP-1 (7-37), the biologically active incretin that led to development of effective GLP-1 …
GLP-1 for Treating Obesity: 2024 Lasker-DeBakey Clinical Medical ...
WEB3 days ago · GLP-1RAs mediate their effects through the multifaceted biology that comes with GLP-1 receptor expression in specific cells in many organs of the body. 7 Clinical studies have documented a wide range of benefits, from cardiovascular and kidney risk reduction to improved functional outcomes in heart failure with preserved ejection fraction ...
Obesity-Drug Pioneers Win Prestigious Lasker Award for Medical …
WEB2 days ago · The trio, recognized with a Lasker in the clinical-research category, will share a US$250,000 prize. Biomedical scientists are enthusiastic about the increasing recognition of GLP-1 research ...
Joel Habener, Svetlana Mojsov, and Lotte Bjerre Knudsen awarded Lasker …
WEB3 days ago · The Lasker Foundation has awarded the 2024 Lasker~DeBakey Clinical Medical Research Award to Joel Habener (Massachusetts General Hospital), Svetlana Mojsov (Rockefeller University), and Lotte Bjerre Knudsen (Novo Nordisk) for their pioneering work on glucagon-like peptide 1 (GLP-1) …
Discovery of GLP-1–Based Drugs for the Treatment of Obesity
WEB2 days ago · 215.13 KB. The 2024 Lasker–DeBakey Clinical Medical Research Award recognizes Drs. Habener, Mojsov, and Knudsen, who developed GLP-1 medicines that have revolutionized the treatment of obesity.
The 2024 Lasker Awards - The Lancet
WEB2 days ago · The Lasker–DeBakey Clinical Medical Research Award was won by Joel Habener (Massachusetts General Hospital, Boston, MA, USA), Svetlana Mojsov (New York, NY, USA), and Lotte Bjerre Knudsen (Nova Nordisk, …
- Some results have been removed